8 Related guidance

8 Related guidance

8.1 The Institute has issued guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia.

  • National Institute for Clinical Excellence (2002). Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. NICE Technology Appraisal Guidance No. 43. London: National Institute for Clinical Excellence. [Replaced by NICE clinical guideline 82]

8.2 The Institute has issued guidance on the use of computerised cognitive behavioural therapy for depressive illness and anxiety,

  • National Institute for Clinical Excellence (2002). Guidance on the use of computerised cognitive behavioural therapy for anxiety and depression. NICE Technology Appraisal Guidance No. 51. London: National Institute for Clinical Excellence. [Replaced by NICE technology appraisal guidance 97]

8.3 The Institute has issued guidance on the management of bipolar disorder in adults, children and adolescents, in primary and secondary care (NICE clinical guideline 38, 2006).

8.4 The Institute has issued guidelines for schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. NICE Clinical Guideline 1. London: National Institute for Clinical Excellence. [Replaced by NICE clinical guideline 82].